1,283
Views
0
CrossRef citations to date
0
Altmetric
Editorial

Extended release anti-VEGF systems: a strategy whose time has come? Or already gone?

Pages 167-169 | Received 01 Mar 2016, Accepted 15 Apr 2016, Published online: 26 May 2016
 

Declaration of interests

M.W. Stewart is on the advisory board for Allergan and Regeneron, is a consultant for Boehringer-Ingelheim and Momenta Pharmaceuticals and has received institutional research support from Allergan and Regeneron. The author has no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.